BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 25668179)

  • 1. US Food and Drug Administration (FDA) approves stand-alone HPV-DNA testing for cervical cancer screening.
    Mani H
    Natl Med J India; 2014; 27(4):241. PubMed ID: 25668179
    [No Abstract]   [Full Text] [Related]  

  • 2. Patient safety and the next generation of HPV DNA tests.
    Lee SH
    Am J Clin Pathol; 2011 Mar; 135(3):481; author reply 482-3. PubMed ID: 21350106
    [No Abstract]   [Full Text] [Related]  

  • 3. Rightsizing cervical cancer screening: comment on "Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone".
    Sawaya GF
    Arch Intern Med; 2010 Jun; 170(11):985-6. PubMed ID: 20548012
    [No Abstract]   [Full Text] [Related]  

  • 4. Statement on HPV DNA test utilization.
    Solomon D; Papillo J; Davis Davey D;
    J Low Genit Tract Dis; 2009 Jul; 13(3):135-6. PubMed ID: 19550209
    [No Abstract]   [Full Text] [Related]  

  • 5. Primary human papillomavirus screening for cervical cancer in the United States-US Food and Drug Administration approval, clinical trials, and where we are today.
    Nayar R; Goulart RA; Tiscornia-Wasserman PG; Davey DD
    Cancer Cytopathol; 2014 Oct; 122(10):720-9. PubMed ID: 25228434
    [No Abstract]   [Full Text] [Related]  

  • 6. Testing for human papillomavirus in cervical cancer screening: a review of indications and methodology.
    Nishino HT; Tambouret RH; Wilbur DC
    Cancer Cytopathol; 2011 Aug; 119(4):219-27. PubMed ID: 21717588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Screening of cervical cancer and test for HPV].
    Hirai Y
    Gan To Kagaku Ryoho; 2010 Feb; 37(2):232-5. PubMed ID: 20235390
    [No Abstract]   [Full Text] [Related]  

  • 8. The rationale for implementation of HPV testing in routine cervical screening in Romania.
    Iancu LS; Ursu RG
    Rev Med Chir Soc Med Nat Iasi; 2013; 117(2):293-6. PubMed ID: 24340506
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary human papillomavirus testing in organized cervical screening.
    Dillner J
    Curr Opin Obstet Gynecol; 2013 Feb; 25(1):11-6. PubMed ID: 23299089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2013 statement on human papillomavirus [corrected] test utilization.
    Davis Davey D; Goulart R; Nayar R;
    Acta Cytol; 2014; 58(2):113-6. PubMed ID: 24525558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early detection of cervical cancer by human papillomavirus DNA testing: case reports.
    Dunton CJ; Dooley M; Holtz DO
    J Low Genit Tract Dis; 2006 Oct; 10(4):256-7. PubMed ID: 17012993
    [No Abstract]   [Full Text] [Related]  

  • 12. Screening: Testing times.
    Humphries C
    Nature; 2012 Aug; 488(7413):S8-9. PubMed ID: 22932440
    [No Abstract]   [Full Text] [Related]  

  • 13. [High-risk human papilloma virus DNA detection kit (cervista HPV HR) should be highly validated clinically in cervical cancer screening programs].
    Zhao J; Zhang XG; Chen R; Bi H; Wang X; Liu GW; Yao DX; Zong Y; Liao QP
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Apr; 25(2):149-51. PubMed ID: 21863645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical cancer screening today. The role of HPV DNA testing.
    Berman NR
    Adv Nurse Pract; 2006 Apr; 14(4):24-9; quiz 30. PubMed ID: 16972469
    [No Abstract]   [Full Text] [Related]  

  • 15. The HPV DNA virus hybrid capture assay: what is it--and where do we go from here?
    Vernick JP; Steigman CK
    MLO Med Lab Obs; 2003 Mar; 35(3):8-10, 13; quiz 14-5. PubMed ID: 12685257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDA panel recommends DNA test as first line cervical cancer screening test.
    McCarthy M
    BMJ; 2014 Mar; 348():g2164. PubMed ID: 24637970
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diagnosis of HPV-related diseases].
    Inoue M
    Nihon Rinsho; 2009 Jan; 67(1):85-93. PubMed ID: 19177756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Commentary on: Statement on HPV DNA test utilization.
    Cox JT; Moriarty AT; Castle PE
    J Low Genit Tract Dis; 2009 Jul; 13(3):131-4. PubMed ID: 19550208
    [No Abstract]   [Full Text] [Related]  

  • 19. [Investigation of HPV-DNA in cervical smear samples by two different methods: MY09/11 consensus PCR and type-specific real-time PCR].
    Sahiner F; Gümral R; Sener K; Yiğit N; Dede M; Yapar M; Kubar A
    Mikrobiyol Bul; 2012 Oct; 46(4):624-36. PubMed ID: 23188576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Commentary on: Statement on HPV DNA test utilization.
    Cox JT; Moriarty AT; Castle PE
    Diagn Cytopathol; 2009 Jul; 37(7):471-4. PubMed ID: 19459174
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.